Adherex Technologies Inc. (ADHXF)
-OTC Markets | Prev Close: | 0.36 |
|---|
| Open: | N/A |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 1.19 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 0.10 - 1.13 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 18,452 |
|---|
| Market Cap: | 8.96M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.48 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- ADHEREX TECHNOLOGIES INC Files SEC form 8-K, Other EventsEDGAR Online(Thu, May 23)
- Adherex Reports Feedback from the FDA from End of Phase 2 MeetingMarketwired(Thu, May 23)
- Adherex Reports Feedback from the FDA from End of Phase 2 MeetingMarketwired(Thu, May 23)
- ADHEREX TECHNOLOGIES INC FinancialsEDGAR Online Financials(Fri, May 17)
- Adherex Reports Recent Developments and First Quarter March 31, 2013 Financial ResultsMarketwired(Mon, May 13)
- Adherex Reports Recent Developments and First Quarter March 31, 2013 Financial ResultsMarketwired(Mon, May 13)
- ADHEREX TECHNOLOGIES INC Files SEC form 10-Q, Quarterly ReportEDGAR Online(Sun, May 12)
- ADHEREX TECHNOLOGIES INC Files SEC form 10-K, Annual ReportEDGAR Online(Mon, Apr 1)
- Adherex Provides Corporate Update and Fiscal Year Ended December 31, 2012 Financial ResultsMarketwired(Mon, Apr 1)
- Adherex Provides Corporate Update and Fiscal Year Ended December 31, 2012 Financial ResultsMarketwired(Mon, Apr 1)
- LifeSci Advisors Announces Investment Opinion on Adherex TechnologiesMarketwired(Fri, Mar 1)
- ADHEREX TECHNOLOGIES INC Files SEC form 8-K, Other EventsEDGAR Online(Mon, Jan 7)
- Adherex Announces Completion of Patient Enrollment and Maintains TSX Listing StatusMarketwired(Sun, Jan 6)
- Adherex Announces Completion of Patient Enrollment and Maintains TSX Listing StatusMarketwired(Sun, Jan 6)
- ADHEREX TECHNOLOGIES INC Files SEC form 8-K, Other EventsEDGAR Online(Mon, Dec 10)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Adherex Technologies Inc., together with its subsidiaries, operates as a development stage biopharmaceutical company with a portfolio of product candidates under development for use in the treatment of cancer.
View More 
0.91%